AC Immune SA (ACIU)
2.905
+0.04
(+1.57%)
USD |
NASDAQ |
Aug 25, 11:50
AC Immune Debt to Equity Ratio : 0.1166 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1166 |
| March 31, 2026 | 0.1365 |
| December 31, 2025 | 0.1012 |
| September 30, 2025 | 0.0746 |
| June 30, 2025 | 0.0658 |
| March 31, 2025 | 0.0546 |
| December 31, 2024 | 0.0483 |
| September 30, 2024 | 0.0237 |
| June 30, 2024 | 0.0262 |
| March 31, 2024 | 0.023 |
| December 31, 2023 | 0.0218 |
| September 30, 2023 | 0.019 |
| June 30, 2023 | 0.0182 |
| March 31, 2023 | 0.0174 |
| December 31, 2022 | 0.0166 |
| September 30, 2022 | 0.0131 |
| June 30, 2022 | 0.013 |
| March 31, 2022 | 0.0129 |
| December 31, 2021 | 0.0125 |
| September 30, 2021 | 0.0143 |
| June 30, 2021 | 0.0142 |
| March 31, 2021 | 0.0104 |
| Date | Value |
|---|---|
| December 31, 2020 | 0.0103 |
| September 30, 2020 | 0.0096 |
| June 30, 2020 | 0.0094 |
| March 31, 2020 | 0.0093 |
| December 31, 2019 | 0.0107 |
| September 30, 2019 | 0.0086 |
| June 30, 2019 | 0.0094 |
| March 31, 2019 | 0.2042 |
| December 31, 2018 | 0.0029 |
| September 30, 2018 | 0.0031 |
| June 30, 2018 | 0.0058 |
| March 31, 2018 | 0.0041 |
| December 31, 2017 | 0.0034 |
| September 30, 2017 | 0.0035 |
| June 30, 2017 | 0.0032 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Basilea Pharmaceutica AG | -- |
| Santhera Pharmaceuticals Holding AG | -- |
| BeOne Medicines Ltd. | 0.3961 |
| CRISPR Therapeutics AG | 0.4487 |
| Idorsia Ltd. | -1.124 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 186.45M |
| Total Liabilities (Quarterly) | 142.85M |
| Shareholders Equity (Quarterly) | 43.60M |
| Current Ratio | 0.9318 |
| Net Debt Paydown Yield | 0.07% |